Rubin Eyal - Insider Non-Derivative Transactions at Protalix BioTherapeutics, Inc. (PLX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 23, 2024, Rubin Eyal's relationship to Protalix BioTherapeutics, Inc. (PLX) is Officer (Sr. VP and CFO), and currently has 669,010 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PLX insiders.
Data Source: SEC.
Rubin Eyal - Insider Non-Derivative Transactions of PLX Common Stock
Rubin Eyal - Insider Non-Derivative Transactions at PLX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 24, 2024 | Acquisition -- (Common Stock) | 99010 | 0 | 669010 |
| Aug 16, 2023 | Acquisition -- (Common Stock) | 201903 | 0 | 570000 |